Investigation of the Potency of KALA and REV Cell‐Penetrating Peptides for In Vitro/In Vivo Delivery of an HPV Multiepitope DNA Construct
Journal of Peptide Science · 2025
DOI: 10.1002/psc.70000 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Peptide Science, 2025. Verfasst von Haleh Feyzyab und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: Cell-Penetrating Peptides, Vaccines, DNA, Epitopes, Papillomavirus Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben.
Abstract (Originalsprache)
Developing human papillomavirus (HPV) therapeutic DNA vaccines requires an effective delivery system, such as cell‐penetrating peptides (CPPs). In the current study, the multiepitope DNA constructs harboring the immunogenic and conserved epitopes of the L1, L2, and E7 proteins of HPV16/18 (pcDNA‐L1‐L2‐E7 and pEGFP‐L1‐L2‐E7) were delivered using KALA and REV CPPs with different properties in vitro and in vivo. Herein, after confirmation of the REV/DNA and KALA/DNA complexes, their stability was investigated against DNase I and serum protease. Then, their entry into HEK‐293T eukaryotic cells was analyzed by qualitative and quantitative methods. Finally, anti‐tumor effects of the peptide/DNA complexes were investigated in the C57BL/6 mouse model. Based on the obtained data, the REV/DNA and KALA/DNA complexes at the N/P ratio of 5:1 demonstrated successful penetration into HEK‐293T cells. Furthermore, in vivo studies represented that the REV/DNA (survival rate: 75%) and KALA/DNA (survival rate: 50%) complexes provided significant protection against C3 tumors in mice. Indeed, REV CPP exhibited a higher survival rate and lower tumor volume than KALA CPP, 50 days after the C3 challenge. These findings represented the potential of KALA and REV CPPs, especially REV, as promising gene delivery systems for developing HPV therapeutic DNA vaccine candidates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
- Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran.
- Blood Diseases Research Center (BDRC), Iranian Comprehensive Hemophilia Care Center, Iran University of Medical Sciences (IUMS), Tehran, Iran.
ORCID-Profile: Azam Bolhassani
Zitieren
APA
Feyzyab, H., Milani, A., Agi, E., Hashemi, M., & Bolhassani, A. (2025). Investigation of the Potency of KALA and REV Cell‐Penetrating Peptides for In Vitro/In Vivo Delivery of an HPV Multiepitope DNA Construct. Journal of Peptide Science. https://doi.org/10.1002/psc.70000
Vancouver
Feyzyab H, Milani A, Agi E, Hashemi M, Bolhassani A. Investigation of the Potency of KALA and REV Cell‐Penetrating Peptides for In Vitro/In Vivo Delivery of an HPV Multiepitope DNA Construct. Journal of Peptide Science. 2025. doi:10.1002/psc.70000
BibTeX
@article{Feyzyab2025,
author = {Feyzyab, Haleh and Milani, Alireza and Agi, Elnaz and Hashemi, Mehrdad and Bolhassani, Azam},
title = {Investigation of the Potency of KALA and REV Cell‐Penetrating Peptides for In Vitro/In Vivo Delivery of an HPV Multiepitope DNA Construct},
journal = {Journal of Peptide Science},
year = {2025},
doi = {10.1002/psc.70000}
}
EUVIMED